Ken Herrmann
Impact in
- Radiology, Nuclear Medicine and Imaging top 0.01%
- Medical Imaging Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- Radiomics and Machine Learning in Medical Imaging
- Pulmonary and Respiratory Medicine top 0.1%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Medical Imaging Techniques and Applications 266
- Radiopharmaceutical Chemistry and Applications 164
-
- Prostate Cancer Diagnosis and Treatment 92
- Prostate Cancer Treatment and Research 47
- Lung Cancer Diagnosis and Treatment 23
- Co-authors
- Wolfgang P. Fendler (162 shared papers)Andreas Konrad Buck (82 shared papers)Markus Schwaiger (47 shared papers)Bernd Joachim Krause (30 shared papers)Johannes G. Czernin (47 shared papers)Boris Alexander Hadaschik (56 shared papers)Constantin Lapa (50 shared papers)Wolfgang Weber (21 shared papers)
- Journals
- Journal of Nuclear Medicine (148 papers)European Journal of Nuclear Medicine and Molecular Imaging (85 papers)Nuklearmedizin - NuclearMedicine (21 papers)Cancers (18 papers)Seminars in Nuclear Medicine (17 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Ken Herrmann
626 papers receiving 26.3k citations
Ken Herrmann's Hit Papers
Peers
Comparison fields: 5 of 145
- Radiology, Nuclear Medicine and Imaging 15.6k
- Pulmonary and Respiratory Medicine 8.4k
- Oncology 2.3k
- Health Informatics 152
- Epidemiology 1.4k
Countries citing papers authored by Ken Herrmann
This map shows the geographic impact of Ken Herrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Herrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Herrmann more than expected).
Fields of papers citing papers by Ken Herrmann
This network shows the impact of papers produced by Ken Herrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Herrmann. The network helps show where Ken Herrmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Herrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 655 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2021 | 1939 |
| 2 | 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 Hit paper breakdown → | 2017 | 628 |
| 3 | PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial Hit paper breakdown → | 2007 | 618 |
| 4 | Assessment of 68 Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer Hit paper breakdown → | 2019 | 610 |
| 5 | Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT Hit paper breakdown → | 2017 | 464 |
| 6 | 2006 | 375 | |
| 7 | 2007 | 303 | |
| 8 | Radiotheranostics in oncology: current challenges and emerging opportunities Hit paper breakdown → | 2022 | 292 |
| 9 | EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT) Hit paper breakdown → | 2019 | 291 |
| 10 | E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET Hit paper breakdown → | 2021 | 269 |
| 11 | Diagnostic Accuracy of 68 Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection Hit paper breakdown → | 2021 | 262 |
| 12 | 2017 | 253 | |
| 13 | PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0 Hit paper breakdown → | 2023 | 241 |
| 14 | 2017 | 224 | |
| 15 | 2020 | 224 | |
| 16 | 2015 | 222 | |
| 17 | [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study Hit paper breakdown → | 2024 | 214 |
| 18 | 2019 | 205 | |
| 19 | Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study Hit paper breakdown → | 2021 | 202 |
| 20 | 2017 | 193 |
About Ken Herrmann
Ken Herrmann is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 655 papers that have together received 26.7k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (266 papers), Radiopharmaceutical Chemistry and Applications (164 papers), Prostate Cancer Diagnosis and Treatment (92 papers), Prostate Cancer Treatment and Research (47 papers), Neuroendocrine Tumor Research Advances (45 papers), Thyroid Cancer Diagnosis and Treatment (27 papers), Peptidase Inhibition and Analysis (24 papers) and Lung Cancer Diagnosis and Treatment (23 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (15.6k citations), Pulmonary and Respiratory Medicine (8.4k citations), Oncology (2.3k citations), Health Informatics (152 citations) and Epidemiology (1.4k citations). Ken Herrmann has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Wolfgang P. Fendler, Andreas Konrad Buck, Markus Schwaiger, Bernd Joachim Krause, Johannes G. Czernin, Boris Alexander Hadaschik, Constantin Lapa, Wolfgang Weber, Stefano Fanti and Matthias Eiber. Their work appears in journals such as Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Nuklearmedizin - NuclearMedicine, Cancers and Seminars in Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.